{"id":"W2150713593","doi":"10.1309/ajcpv2i0hgpmgbsq","title":"Emerging Technologies for Assessing HER2 Amplification","year":2009,"lang":"en","type":"review","venue":"American Journal of Clinical Pathology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"CISH; Chromogenic in situ hybridization; Immunohistochemistry; In situ hybridization; Trastuzumab; Human Epidermal Growth Factor Receptor 2; Fluorescence in situ hybridization; Chromogenic; Concordance; Breast cancer; Pathology; In situ; Fish <Actinopterygii>; Biology; Medicine; Cancer; Internal medicine; Chemistry; Bioinformatics; Genetics; Messenger RNA","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005589417,0.0003579872,0.005494073,0.0006331853,0.00007550463,0.00003859119,0.0006407442,0.0005780347,0.00002092034],"category_scores_gemma":[0.0110255,0.0002570207,0.001693768,0.000705558,0.001176483,0.00008422483,0.00008391576,0.002656928,0.00002204657],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002013398,"about_ca_system_score_gemma":0.002089335,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002631016,"about_ca_topic_score_gemma":7.35489e-7,"domain_scores_codex":[0.9938564,0.0009153993,0.003707308,0.0005115567,0.0004684996,0.0005407838],"domain_scores_gemma":[0.9905873,0.003356591,0.00444895,0.0006927081,0.0006838209,0.0002306624],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008135213,0.000171583,0.0001864524,0.001563521,0.000158389,0.0003366969,0.00001270431,2.828671e-7,0.000002028791,0.00005203939,0.001323657,0.9961113],"study_design_scores_gemma":[0.0005811271,0.003901409,0.0002800009,0.008059585,0.001065242,0.002673686,0.0002628791,0.000003679461,0.000001316218,0.0004255773,0.9825339,0.0002115489],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001981316,0.9881691,0.006797793,0.002892093,0.000750858,0.0007471238,0.00001149427,0.0000735199,0.0003598729],"genre_scores_gemma":[0.0003731893,0.9685273,0.02939378,0.0003270643,0.001169951,0.00004081761,0.00001675653,0.00007307372,0.00007807081],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9958997,"threshold_uncertainty_score":0.9999882,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3066237885235228,"score_gpt":0.620314042129059,"score_spread":0.3136902536055363,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}